{"filing":{"accession_number":"0001213900-26-061039","cik":"0001139685","ticker":"AIDX","company_name":"20/20 Biolabs, Inc.","form":"8-K","filing_date":"2026-05-26","report_date":null,"primary_document":"ea0292180-8k_2020bio.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/ea0292180-8k_2020bio.htm"},"events":[{"id":9066,"run_id":7961,"accession_number":"0001213900-26-061039","anchor_item_number":"3.03","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"The Board adopted Amendment No. 1 to reduce the quorum requirement for stockholder meetings from a majority to one-third of shares outstanding, materially modifying stockholder rights and governance dynamics.","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-05-26","form":"8-K","submitted_at":null,"items":[{"id":1553,"accession_number":"0001213900-26-061039","item_number":"3.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The Board adopted Amendment No. 1 to reduce the quorum requirement for stockholder meetings from a majority to one-third of shares outstanding. While this is a material modification to stockholder rights under Item 3.03, it does not fit neatly into the specific event taxonomy (it is neither a routine bylaw amendment nor a dilutive issuance, M\u0026A activity, or other defined event). The reduction in quorum materially affects governance and could facilitate shareholder action, making it material to investors' assessment of corporate control dynamics.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:14:18.531870+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1554,"accession_number":"0001213900-26-061039","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.65,"reasoning":"Item 5.03 discloses amendments to articles of incorporation or bylaws, which are typically routine administrative matters. The section references Item 3.03 (incorporation by reference) but provides no substantive detail about the nature of the amendment. Without visibility into the actual amendment content, this appears to be a procedural disclosure that would not materially affect a reasonable investor's assessment of the registrant unless the amendment involved a significant governance change (e.g., anti-takeover provisions, voting rights modification). The lack of detail and cross-reference structure suggests routine administrative disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:14:18.531870+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1553,"accession_number":"0001213900-26-061039","item_number":"3.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The Board adopted Amendment No. 1 to reduce the quorum requirement for stockholder meetings from a majority to one-third of shares outstanding. While this is a material modification to stockholder rights under Item 3.03, it does not fit neatly into the specific event taxonomy (it is neither a routine bylaw amendment nor a dilutive issuance, M\u0026A activity, or other defined event). The reduction in quorum materially affects governance and could facilitate shareholder action, making it material to investors' assessment of corporate control dynamics.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:14:18.531870+00:00","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-05-26"},{"id":1554,"accession_number":"0001213900-26-061039","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.65,"reasoning":"Item 5.03 discloses amendments to articles of incorporation or bylaws, which are typically routine administrative matters. The section references Item 3.03 (incorporation by reference) but provides no substantive detail about the nature of the amendment. Without visibility into the actual amendment content, this appears to be a procedural disclosure that would not materially affect a reasonable investor's assessment of the registrant unless the amendment involved a significant governance change (e.g., anti-takeover provisions, voting rights modification). The lack of detail and cross-reference structure suggests routine administrative disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:14:18.531870+00:00","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-05-26"}]}